Reduction of Test Segment Blood Flow during Hypoxia Test Segment : Percent of Total Lung Increase Perfusion Pressure during Hypoxia

240$ Pulmonary Vascular Reactivity 40 Lauweryns JM, Cokelaere M, Theunynck P. Serotonin producing neuroepithelial bodies in rabbit respiratory mucosa. Science 1973; 180:410-13 41 Keith IM, Will JA. Hypoxia and the neonatal rabbit lung: neuroendocrine cell numbers, 5-HT fluorescence intensity, and the relationship to arterial thickness. Thorax 1981; 36:767-73 42 Lauweryns JM, de Bock V, Guelinckx P, Decramer M. Effects of unilateral hypoxia on neuroepithelial bodies in rabbit lungs. J Appl Physiol 1983; 55:1665-68 43 Grant BJB, Davies EE, Jones HA, Hughes JMB. Local regulation of pulmonary blood flow and ventilation-perfusion ratios in the coatimundi. J Appl Physiol 1976; 40:216-28 44 Charan NB, Turk GM, Dhand R. Gross and subgross anatomy of bronchial circulation in sheep. J Appl Physiol 1984; 57:658-64 45 Duling BR, Berne RM. Propagated vasodilation in the microcirculation of the hamster cheek pouch. Circ Res 1970; 26:163-70 46 Jackson WF, Duling BR. The oxygen sensitivity of hamster cheek pouch arterioles. Circ Res 1983; 53:515-25 47 Miller MA, Greene R, Hales CA. Role of serotonin in alveolar hypoxic vasoconstriction (AHV). Fed Proc 1979; 38:1379 48 Kulik TJ, Johnson DE, Elde R1 Lock JE. Pulmonary vascular effects of bombesin and gastrin-releasing peptide in conscious newborn lambs. J Appi Physiol 1983; 55:1093-97 49 Hales CA, Rouse ET, Kazemi H. Failure of saralasin acetate, a competitive inhibitor of angiotensin II, to diminish alveolar hypoxic vasoconstriction in the dog. Cardiovasc Res 1977; 11:541-46 50 Hales CA, Rouse E, Buchwald IA, Kazemi H. Role ofprostaglandins in alveolar hypoxic vasoconstriction. Respir Physiol 1977; 29:151-62 51 Morganroth ML, Reeves JT, Murphy BC, Voelkel NE Leukotriene synthesis and receptor blockers block hypoxic pulmonary vasoconstriction. J AppI Physiol 1984; 56:1340-46 52 Ahmed T, Olver W. Does slow reacting substance of anaphylaxis mediate hypoxic pulmonary vasoconstriction. Am Rev Respir Dis 1983; 127:566-71 53 Voelkel NF, Stenmark KR, Reeves JT, Mathias MM, Murphy RC. Actions of lipoxygenase metabolites in isolated rat lungs. J AppI Physiol 1984; 57:860-67 54 Bergofsky EH, Holtzman S. A study of the mechanisms involved in the pulmonary arterial pressor response to hypoxia. Circ Res 1967; 20:506-19 55 Duke HN, Killick EM. Pulmonary vasomotor responses of isolated perfused cat lungs to anoxia. J Physiol 1952; 117:303-16 56 Sylvester JT, McCowna C. The effects of agents that bind cytochrome P450 on hypoxic pulmonary vasoconstriction. Circ Res 1978; 43:429-37 57 Miller MA, Hales CA. Role of cytochrome P450 in alveolar hypoxic pulmonary vasoconstriction in dogs. J Clin Invest 1979; 64:666-73 58 McMurtry IF, Davidson AB, Reeves JT, Grover RT. Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circ Res 1976; 38:99-104 59 Rounds S. McMurtry IF Inhibitors of oxidative ATP production cause transient vasoconstriction and block subsequent pressor responses in cat lungs. Circ Res 1981; 48:393-400 60 McMurtry IF, Rounds 5, Stanbrook HS. Studies of the mechanism of hypoxic pulmonary vasoconstriction. Adv Shock Res 1982; 8:21-33 DIscussIoN